Stocks and InvestingStocks and Investing
Fri, January 7, 2022
Thu, January 6, 2022
Wed, January 5, 2022
Tue, January 4, 2022

Matt O"Brien Downgraded (ZBH) to Hold and Decreased Target to $135 on, Jan 4th, 2022


Published on 2024-10-27 19:07:14 - WOPRAI, Matt O'Brien
  Print publication without navigation


Matt O"Brien of Piper Sandler, Downgraded "Zimmer Biomet Holdings, Inc." (ZBH) to Hold and Decreased Target from $185 to $135 on, Jan 4th, 2022.

Matt has made no other calls on ZBH in the last 4 months.

There are 10 other peers that have a rating on ZBH. Out of the 10 peers that are also analyzing ZBH, 3 agree with Matt"s Rating of Hold. Following are those relevant analyst calls for the last 4 months;

Shagun Singh of "RBC Capital" Initiated at Hold and Held Target at $140 on, Friday, December 10th, 2021
David Toung of "Argus Research" Downgraded from Strong Buy to Hold on, Tuesday, November 23rd, 2021
Pito Chickering of "Deutsche Bank" Maintained at Hold with Decreased Target to $140 on, Friday, November 5th, 2021

These are the ratings of the 7 analyists that currently disagree with Matt;

Richard Newitter of "Truist Securities" Maintained at Strong Buy with Decreased Target to $145 on, Tuesday, December 21st, 2021
Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $150 on, Wednesday, December 15th, 2021
Mike Matson of "Needham" Downgraded at Strong Buy and Decreased Target to $158 on, Thursday, December 9th, 2021
Jason Wittes of "Loop Capital" Initiated at Strong Buy and Held Target at $165 on, Tuesday, December 7th, 2021
David Turkaly of "JMP Securities" Maintained at Buy with Decreased Target to $175 on, Friday, November 5th, 2021
Anthony Petrone of "Jefferies" Maintained at Strong Buy with Decreased Target to $175 on, Friday, November 5th, 2021
Travis Steed of "Barclays" Maintained at Buy with Decreased Target to $186 on, Tuesday, October 5th, 2021